Radley, Andrewde Bruin, MarijnInglis, Sarah K.Donnan, Peter T.Hapca, AdrianBarclay, Stephen T.Fraser, AndrewDillon, John F.2020-12-082020-12-082020-09-01Radley, A, de Bruin, M, Inglis, S K, Donnan, P T, Hapca, A, Barclay, S T, Fraser, A & Dillon, J F 2020, 'Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy : A pragmatic cluster randomised trial', The Lancet Gastroenterology & Hepatology, vol. 5, no. 9, pp. 809-818. https://doi.org/10.1016/S2468-1253(20)30120-52468-1253https://hdl.handle.net/2164/15472Funding: Partnership between the Scottish Government, Gilead Sciences, and Bristol-Myers Squib.10416939engSDG 3 - Good Health and Well-beingGLOBAL PREVALENCECAREINTERVENTIONSINFECTIONBARRIERSPEOPLEHCVR Medicine (General)GastroenterologyHepatologySupplementary DataR1Journal article10.1016/S2468-1253(20)30120-5http://www.scopus.com/inward/record.url?scp=85086946581&partnerID=8YFLogxK59